Skip to main content
OpenTrials

Clinical trial condition

Skin and Connective Tissue Diseases

Explore clinical trials studying Skin and Connective Tissue Diseases. Study availability and eligibility vary by location and protocol.

28,066 public trials 4,388 recruiting studies
Refine in advanced search Browse all conditions

Skin and Connective Tissue Diseases trial results

Recruiting

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

NCT06400472

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +42 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
  • NYU Langone Health - Long Island Mineola, New York, United States
View all 24 locations
View Trial Details
Recruiting

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

NCT07114601

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +37 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
View all 33 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

NCT06617325

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Sl0044 50058 Avondale, Arizona, United States
  • Sl0044 50550 Chandler, Arizona, United States
  • Sl0044 50713 Gilbert, Arizona, United States
  • Sl0044 50662 Glendale, Arizona, United States
View all 242 locations
View Trial Details
Recruiting

Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)

NCT07428499

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +17 more
Locations
  • ADARx Clinical Site Litchfield Park, Arizona, United States
  • ADARx Clinical Site Little Rock, Arkansas, United States
  • ADARx Clinical Site San Diego, California, United States
  • ADARx Clinical Site Walnut Creek, California, United States
View all 48 locations
View Trial Details
Recruiting

An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

NCT07665437

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Novartis Investigative Site Caba, Buenos Aires, Argentina
  • Novartis Investigative Site CABA, Argentina
  • Novartis Investigative Site Sydney, New South Wales, Australia
  • Novartis Investigative Site Melbourne, Victoria, Australia
View all 19 locations
View Trial Details
Recruiting

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

NCT05136196

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III Cutaneous Melanoma AJCC v8, +52 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
View all 229 locations
View Trial Details

Related conditions